Verrica Pharmaceuticals Inc. (VRCA) Net Income by Year
Verrica Pharmaceuticals Inc. reported a net loss of $17.9M in fiscal year 2025. This represents an increase of 76.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $31.2M net loss. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Verrica Pharmaceuticals Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VRCA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
VRCA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Verrica Pharmaceuticals Inc. financials
Frequently Asked Questions
What was Verrica Pharmaceuticals Inc.'s net income in fiscal year 2025?
Verrica Pharmaceuticals Inc. reported a net loss of $17.9M in fiscal year 2025.
How fast is Verrica Pharmaceuticals Inc.'s net income growing?
Verrica Pharmaceuticals Inc. (VRCA) net income rose by 76.6% year over year, from -$76.6M to -$17.9M in fiscal year 2025.
What is Verrica Pharmaceuticals Inc.'s net income over the last twelve months?
Verrica Pharmaceuticals Inc. (VRCA) reported a $31.2M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Verrica Pharmaceuticals Inc.'s net income changed over the years?
Across the 9 fiscal years this page covers, Verrica Pharmaceuticals Inc. (VRCA) net income went from -$4.5M in fiscal year 2017 to -$17.9M in fiscal year 2025.
What was Verrica Pharmaceuticals Inc.'s net income in the most recent quarter?
Verrica Pharmaceuticals Inc. (VRCA) reported -$13.2M in net income in Q2 2026. This represents a decrease of 6547.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Verrica Pharmaceuticals Inc. (VRCA) reported on that line in every period on record.